{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:33Z","timestamp":1793500533879,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Nature Science Foundation of Fujian Province of China","award":["2024J0112"],"award-info":[{"award-number":["2024J0112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12264-9","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T20:06:50Z","timestamp":1764446810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Disseminated Talaromyces marneffei infection mimicking tuberculosis in an HIV-negative adult with anti\u2013IFN-\u03b3 autoantibodies: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiewei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"1","key":"12264_CR1","doi-asserted-by":"publisher","first-page":"e0005122","DOI":"10.1128\/cmr.00051-22","volume":"36","author":"F Wang","year":"2023","unstructured":"Wang F, Han R, Chen S. An overlooked and underrated endemic Mycosis-Talaromycosis and the pathogenic fungus talaromyces Marneffei. Clin Microbiol Rev. 2023;36(1):e0005122.","journal-title":"Clin Microbiol Rev"},{"key":"12264_CR2","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.2147\/IDR.S471938","volume":"17","author":"Q Li","year":"2024","unstructured":"Li Q, Li M, Wang S, Geater AF, Dai J. Clinical diagnostic challenge in a case of disseminated talaromyces Marneffei infection misdiagnosed initially as pulmonary tuberculosis: A case report and literature review. Infect Drug Resist. 2024;17:3751\u20137.","journal-title":"Infect Drug Resist"},{"key":"12264_CR3","doi-asserted-by":"publisher","first-page":"107359","DOI":"10.1016\/j.ijid.2024.107359","volume":"151","author":"J Zhou","year":"2025","unstructured":"Zhou J, Xi D, Teng Y, Zong S, Zeng G. Prevalence of bone destruction in patients with TALAROMYCES MARNEFFEI infection: A systematic review and meta-analysis. Int J Infect Dis. 2025;151:107359.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"12264_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","volume":"103","author":"C Hoflich","year":"2004","unstructured":"Hoflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Docke WD, Grutz G, Meisel C, Halle E, Gobel UB, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and burkholderia cocovenenans. Blood. 2004;103(2):673\u20135.","journal-title":"Blood"},{"issue":"11","key":"12264_CR5","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1128\/AAC.37.11.2407","volume":"37","author":"K Supparatpinyo","year":"1993","unstructured":"Supparatpinyo K, Nelson KE, Merz WG, Breslin BJ, Cooper CR Jr., Kamwan C, Sirisanthana T. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated penicillium Marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother. 1993;37(11):2407\u201311.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"12264_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/infdis\/jiae343","volume":"231","author":"G Yin","year":"2025","unstructured":"Yin G, Yin Y, Guo Y, Sun L, Ma S, Chen H, Wang Q, Wang H. Clinical impact of plasma metagenomic Next-Generation sequencing on infection diagnosis and antimicrobial therapy in immunocompromised patients. J Infect Dis. 2025;231(2):344\u201354.","journal-title":"J Infect Dis"},{"key":"12264_CR7","doi-asserted-by":"crossref","unstructured":"Jiang L, Liang TW, Al-Odaini N, Hu Y, Huang ML, Wei LL, Li XY, Pan KS, Zheng DY, Jiang ZW, et al. Metagenomic next-generation sequencing as an effective diagnostic tool for talaromycosis in HIV-negative patients. Mycopathologia. 2024;189(4).","DOI":"10.1007\/s11046-024-00866-x"},{"key":"12264_CR8","doi-asserted-by":"crossref","unstructured":"Dow CT, Lin NW, Chan ED. Sarcoidosis, mycobacterium paratuberculosis and noncaseating granulomas: who moved my cheese. Microorganisms. 2023;11(4).","DOI":"10.3390\/microorganisms11040829"},{"issue":"1","key":"12264_CR9","doi-asserted-by":"publisher","first-page":"e70055","DOI":"10.1111\/imr.70055","volume":"333","author":"TMN Camarasa","year":"2025","unstructured":"Camarasa TMN, Iseppi L, Schreiner D, King CG. Tertiary lymphoid structures in tuberculosis: Persistence, Protection, and pathology. Immunol Rev. 2025;333(1):e70055.","journal-title":"Immunol Rev"},{"key":"12264_CR10","doi-asserted-by":"publisher","first-page":"1427559","DOI":"10.3389\/fimmu.2024.1427559","volume":"15","author":"J Lyu","year":"2024","unstructured":"Lyu J, Narum DE, Baldwin SL, Larsen SE, Bai X, Griffith DE, Dartois V, Naidoo T, Steyn AJC, Coler RN, et al. Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Front Immunol. 2024;15:1427559.","journal-title":"Front Immunol"},{"issue":"1","key":"12264_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/21505594.2019.1593776","volume":"10","author":"M Payne","year":"2019","unstructured":"Payne M, Weerasinghe H, Tedja I, Andrianopoulos A. A unique aspartyl protease gene expansion in talaromyces Marneffei plays a role in growth inside host phagocytes. Virulence. 2019;10(1):277\u201391.","journal-title":"Virulence"},{"issue":"3","key":"12264_CR12","first-page":"e19","volume":"5","author":"JF Chan","year":"2016","unstructured":"Chan JF, Lau SK, Yuen KY, Woo PC. Talaromyces (Penicillium) Marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016;5(3):e19.","journal-title":"Emerg Microbes Infect"},{"key":"12264_CR13","doi-asserted-by":"crossref","unstructured":"Guo J, Ning XQ, Ding JY, Zheng YQ, Shi NN, Wu FY, Lin YK, Shih HP, Ting HT, Liang G, et al. Anti-IFN-gamma autoantibodies underlie disseminated talaromyces Marneffei infections. J Exp Med. 2020;217(12).","DOI":"10.1084\/jem.20190502"},{"issue":"1","key":"12264_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12348-016-0106-z","volume":"6","author":"TL Lee","year":"2016","unstructured":"Lee TL, Agrawal R, Tan JY, Ong KH, Wong CS, Ho SL. Disseminated nontuberculous mycobacterial infection with multifocal retinitis and vasculitis in an immunocompromised patient with anti-IFN-\u0263 autoantibodies. J Ophthalmic Inflamm Infect. 2016;6(1):39.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"4","key":"12264_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.diagmicrobio.2017.05.011","volume":"88","author":"I Hase","year":"2017","unstructured":"Hase I, Morimoto K, Sakagami T, Ishii Y, van Ingen J. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review. Diagn Microbiol Infect Dis. 2017;88(4):308\u201315.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"12264_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.5312\/wjo.v12.i11.938","volume":"12","author":"CH Yang","year":"2021","unstructured":"Yang CH, Kuo FC, Lee CH. Pathological humerus fracture due to anti-interferon-gamma autoantibodies: A case report. World J Orthop. 2021;12(11):938\u201344.","journal-title":"World J Orthop"},{"issue":"1","key":"12264_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12879-019-3771-3","volume":"19","author":"X Xu","year":"2019","unstructured":"Xu X, Lao X, Zhang C, Cao C, Ding H, Pang Y, Ning Q, Zou J, Zang N, Hu D, et al. Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis possibly secondary to anti-interferon-gamma autoantibody formation. BMC Infect Dis. 2019;19(1):203.","journal-title":"BMC Infect Dis"},{"key":"12264_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nmni.2018.10.001","volume":"27","author":"H Namkoong","year":"2019","unstructured":"Namkoong H, Asakura T, Ishii M, Yoda S, Masaki K, Sakagami T, Iwasaki E, Yamagishi Y, Kanai T, Betsuyaku T, et al. First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies. New Microbes New Infect. 2019;27:4\u20136.","journal-title":"New Microbes New Infect"},{"key":"12264_CR19","doi-asserted-by":"publisher","first-page":"1097514","DOI":"10.3389\/fmed.2022.1097514","volume":"9","author":"PK Chen","year":"2022","unstructured":"Chen PK, Liao TL, Chang SH, Yeo KJ, Chou CH, Chen DY. High-titer anti-interferon-gamma neutralizing autoantibodies linked to opportunistic infections in patients with adult-onset still\u2019s disease. Front Med (Lausanne). 2022;9:1097514.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"12264_CR20","doi-asserted-by":"publisher","first-page":"300060520976471","DOI":"10.1177\/0300060520976471","volume":"49","author":"W Jin","year":"2021","unstructured":"Jin W, Liu J, Chen K, Shen L, Zhou Y, Wang L. Coinfection by talaromyces Marneffei and Mycobacterium abscessus in a human immunodeficiency virus-negative patient with anti-interferon-gamma autoantibody: a case report. J Int Med Res. 2021;49(1):300060520976471.","journal-title":"J Int Med Res"},{"issue":"7","key":"12264_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1177\/1535370220981579","volume":"246","author":"K Chawansuntati","year":"2021","unstructured":"Chawansuntati K, Rattanathammethee K, Wipasa J. Minireview: insights into anti-interferon-gamma autoantibodies. Exp Biol Med (Maywood). 2021;246(7):790\u20135.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"6","key":"12264_CR22","doi-asserted-by":"publisher","first-page":"ofab181","DOI":"10.1093\/ofid\/ofab181","volume":"8","author":"S Uno","year":"2021","unstructured":"Uno S, Uehara E, Kimura T, Sakagami T, Namkoong H, Uchida S, Uwamino Y, Hasegawa N. R-CHOP chemotherapy for disseminated Mycobacterium avium complex disease due to Anti-Interferon-Gamma autoantibodies: A case report. Open Forum Infect Dis. 2021;8(6):ofab181.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"12264_CR23","doi-asserted-by":"publisher","first-page":"e0215581","DOI":"10.1371\/journal.pone.0215581","volume":"14","author":"N Angkasekwinai","year":"2019","unstructured":"Angkasekwinai N, Suputtamongkol Y, Phoompoung P, Pithukpakorn M, Wongswat E, Umrod P, Tongsai S, Foongladda S. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-gamma autoantibodies. PLoS ONE. 2019;14(4):e0215581.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12264-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12264-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12264-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:04:30Z","timestamp":1767477870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12264-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12264"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12264-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7093354\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were conducted in accordance with the ethical standards of the Ethics Committee of the 900th Hospital of the Joint Logistic Support Force and with the Declaration of Helsinki. (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval to participate"}},{"value":"We have obtained written informed consent from the patient, and the clinical details, along with any identifying images, are authorized for publication for academic exchange.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}